ISHO Announces AI Sleep Tech Strategy and Goal for 1,000 PSG Datasets
AI sleep technology startup ISHO held its product launch event, where founder Wang Teng announced the company's new corporate strategy focused on precise monitoring, scientific intervention, and energy recovery. The company also revealed plans to collect over 1,000 gold-standard clinical PSG datasets within a year. This announcement highlights the ongoing convergence of consumer health tech and clinical data, as companies increasingly attempt to validate consumer sleep products using medical-grade standards. Expanding the scope from nighttime sleep to daytime energy status reflects a broader industry trend toward holistic, round-the-clock wellness monitoring. The newly unveiled AI technology framework, ISHO Intelligence, combines professional sleep science, AI algorithms, and hardware-software product development. The initiative aims to shift research focus beyond simple sleep quality metrics into post-awakening scenarios and daily vitality.
## BACKGROUND
Polysomnography (PSG) is a non-invasive diagnostic test that simultaneously records multiple physiological parameters such as brain waves, eye movements, muscle activity, and heart rate during sleep. It is widely considered the gold standard in clinical medicine for diagnosing sleep disorders such as obstructive sleep apnea and periodic limb movement disorders.